Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Classificação em ações #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Preço da ação
$7.15
Valor de mercado
$313.60M
Variação (1 dia)
-2.12%
Variação (1 ano)
-84.14%
País
DE
Negociar Anbio Biotechnology Class A Ordinary Shares (NNNN)

Categoria

Rácio P/S de Anbio Biotechnology Class A Ordinary Shares (NNNN)
Rácio P/S em 2026 TTM: 0
De acordo com os relatórios financeiros mais recentes e o preço das ações da Anbio Biotechnology Class A Ordinary Shares, o rácio P/S atual (TTM) é 0. No final de 2026, o rácio P/S era 0.
Histórico do rácio P/S da Anbio Biotechnology Class A Ordinary Shares de 2026 a 2026
Rácio P/S no final de cada ano
Ano Rácio P/S Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/S de empresas semelhantes ou concorrentes
Empresa Rácio P/S Diferença do rácio P/S País
12.07 -
US
2.52 -
FR
- -
JP
2.49 -
US
- -
CH